Correlation Between CRISPR Therapeutics and Origin Agritech

Can any of the company-specific risk be diversified away by investing in both CRISPR Therapeutics and Origin Agritech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CRISPR Therapeutics and Origin Agritech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CRISPR Therapeutics AG and Origin Agritech, you can compare the effects of market volatilities on CRISPR Therapeutics and Origin Agritech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CRISPR Therapeutics with a short position of Origin Agritech. Check out your portfolio center. Please also check ongoing floating volatility patterns of CRISPR Therapeutics and Origin Agritech.

Diversification Opportunities for CRISPR Therapeutics and Origin Agritech

-0.5

Correlation Coefficient

CRISPR Therapeutics  Origin Agritech

Very good diversification

The 3 months correlation between CRISPR and Origin is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding CRISPR Therapeutics AG and Origin Agritech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Origin Agritech and CRISPR Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CRISPR Therapeutics AG are associated (or correlated) with Origin Agritech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Origin Agritech has no effect on the direction of CRISPR Therapeutics i.e., CRISPR Therapeutics and Origin Agritech go up and down completely randomly.

Pair Corralation between CRISPR Therapeutics and Origin Agritech

Assuming the 90 days trading horizon CRISPR Therapeutics AG is expected to generate 1.02 times more return on investment than Origin Agritech. However, CRISPR Therapeutics is 1.02 times more volatile than Origin Agritech. It trades about 0.14 of its potential returns per unit of risk. Origin Agritech is currently generating about -0.15 per unit of risk. If you would invest  4,080  in CRISPR Therapeutics AG on April 23, 2025 and sell it today you would earn a total of  1,570  from holding CRISPR Therapeutics AG or generate 38.48% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

CRISPR Therapeutics AG  vs.  Origin Agritech

CRISPR Therapeutics

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in CRISPR Therapeutics AG are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, CRISPR Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Origin Agritech

Risk-Adjusted Performance

Very Weak

Over the last 90 days Origin Agritech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in August 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with CRISPR Therapeutics and Origin Agritech

The main advantage of trading using opposite CRISPR Therapeutics and Origin Agritech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CRISPR Therapeutics position performs unexpectedly, Origin Agritech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Origin Agritech will offset losses from the drop in Origin Agritech's long position.

The idea behind CRISPR Therapeutics AG and Origin Agritech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.